CMOTEC_B: Animal Care sales surged and global reach expanded, but funding needs remain

About this update from Scandinavian Chemotech Ab Class B

Q1 2025 saw strong Animal Care sales growth and global expansion, while Human Care focused on clinical trials. Losses narrowed, but additional funding is needed for continued operations. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Chemotech Ab Class B